PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

CPhI Worldwide report highlights unpredictability in CDMO growth over next 5-years

Flow chemistry, fermentation, repatriation of overseas funds, oncology and API/product integration to grow, but the rate of change remains unclear CPhI Worldwide – h...
Continue Reading →
News

Advanced Accelerator Applications Announces European Approval of Lutathera® for Gastroenteropancreatic Neuroendocrine (GEP-NET) Tumours

Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA), an international specialist in Molecular Nuclear Medicine (MNM), announced that the European Commission (...
Continue Reading →
News

Redefine safety with tamper-evident labelling

Even in a world that has become increasingly virtual and digital, safeguarding the physical integrity of some products has never been more important. The need to pro...
Continue Reading →
News

Workshop on “Continuous Manufacturing: L. B. Bohle invites experts to a three-day symposium

40 pharmaceutical experts from all over the world test the processes of the future in the Technology Center Special machine builder L.B. Bohle Maschinen + Verfa...
Continue Reading →
News

Increasing usage of medical device therapy expected to hinder primary axillary hyperhidrosis drug market growth, says GBI Research

The primary axillary hyperhidrosis therapeutics market value is expected to increase at a slow pace in the coming years, from $541.9 million in 2016 to $680.7 millio...
Continue Reading →
News

Pertinax Pharma launches patented chlorhexidine technology – Pertinax®

Novel materials enable controlled and sustained release of chlorhexidine across a multitude of applications Pertinax Pharma announces the commercial launch of i...
Continue Reading →
News

Gyros Protein Technologies signs distribution agreement with Euro Diagnostica

Gyros Protein Technologies becomes distributor of iLite cell-based reporter gene assays for drug development   Uppsala and Malmö, Sweden: Gyros Protein Technolo...
Continue Reading →
News

Envigo Appointment of New Business Lead Consultant further Strengthens Regulatory Consultant Team

The company’s unique full service offering for regulatory advice and research bolstered by further investment in consulting expertise Princeton, NJ, USA - Envig...
Continue Reading →
News

Gerresheimer in Q3 2017: Slight improvement in adjusted EBITDA margin

After a moderate nine months, Gerresheimer AG expects a recovery in revenues in the fourth quarter. Despite the fall in revenues in the third quarter 2017, the stric...
Continue Reading →
News

SAUDIA CARGO uses Opticooler for temperature controlled shipments

The newest technology of active containers is now available for temperature-sensitive goods on SAUDIA CARGO flights with the RKN and RAP Opticooler of DoKaSch Temper...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026